XTalks
DECEMBER 20, 2023
In 2023, there were significant advancements and notable trends in the life sciences. Xtalks compiled a list of its top life science news and trends of 2023, which provided readers with the latest developments, information and expert insights across life science industries, including pharma, biotech and medical device.
XTalks
NOVEMBER 2, 2023
The biosimilar to Johnson & Johnson’s Stelara is approved for use by adults for the listed indications, as well as pediatric patients six years of age and older for the dermatologic indications (plaque psoriasis and psoriatic arthritis). billion in sales, accounting for ten percent of Johnson & Johnson’s revenue.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
XTalks
JULY 16, 2021
Related: Google Launches AI-Based Dermatology Assist Tool. In light of the benzene contamination, “While the use of these products would not be expected to cause adverse health consequences,” the company says it was the “right decision” to ask customers to stop using them. Benzene is a colorless flammable liquid that has a sweet odor.
pharmaphorum
JULY 8, 2022
Pharma companies have begun to explore a host of novel digital endpoints that could have far-reaching implications for accelerating drug development and adoption. His career includes nearly 20 years leading global drug development, clinical research, and decentralised clinical trials (DCTs) for life science organisations.
The Pharma Data
DECEMBER 17, 2020
Martin Carter Professor in Clinical Investigation and Head of the Laboratory of Investigative Dermatology at The Rockefeller University and Weinblatt is the co-director of Clinical Rheumatology at the Brigham and Women’s Hospital. Recro – CDMO company Recro announced David Enloe as its new president and CEO.
Expert insights. Personalized for you.
59 
Let's personalize your content